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usage data. By potentially avoiding a diagnosis of HIT/HITT in
these patients, the hospital would realize an annualized savings
of over $86,000.
Conclusion: Normal saline has demonstrated historical
noninferiority to heparin for maintaining PICC patency when
used as the capping solution with positive pressurized caps.
Similar results were found during our pilot.
Cost-Effectiveness
Therapy

of
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Background: With over 40 years of demonstrated clinical
efficacy, warfarin remains the world’s most used pharmaceutical
to prevent ischemic stroke in patients with atrial fibrillation
(AF). However, warfarin has many challenges. Thus, despite
known effectiveness, warfarin is a leading cause to druginduced morbidity and mortality. Over 50 different warfarin
therapy protocols, including a number of pharmacogenomicbased (PG) protocols, with as many as 14 independent variables,
have been developed to improve safety and efficacy, thereby
reducing ischemic strokes and intracranial hemorrhages (ICH).
Purpose: To conduct a preliminary cost-effectiveness study to
determine the price point at which using warfarin PG dosing to
prevent ischemic stroke and ICH would provide a neutral cost
difference for the AF patient population at Aurora Health Care.
Methods: Using a 15-year retrospective electronic medical
record, we generated a large enough simulated AF population
using Bayesian Network modeling to conduct a series of
simulated warfarin therapies. We used five different PG and
non-PG warfarin therapy protocols. The protocols with various
levels of personalization used different PG and non-PG dosing
algorithms for initial, adjustment and maintenance warfarin
dosing. The simulation platform was able to predict daily
international normalized ratio values and the rate of ischemic
stroke and ICH in each simulated patient over 90 days for
each of the five warfarin therapy protocols. Using nationwide
estimates derived through literature review, we estimated the
total cost of administering warfarin using the five different
protocols and subsequent acute and 5-year care costs (adjusted
according to annual Medical Care Component of the Consumer
Price Index).
Results: In 2000–2015, a total of 48,006 patients, or ~3,000
patients annually, initiated warfarin therapy with a primary
diagnosis of AF at Aurora. We found that Aurora’s current best
practice warfarin therapy protocol had the highest predicted
costs for ICH, resulting in $163,462.55 for acute care costs
(averaged over 1,000 patients) and $171,279.60 for 5-year
ongoing care related to ICH. The current Aurora protocol
also had the highest associated costs for ischemic stroke at
$51,333.45 for acute care and $58,507.21 for 5-year ongoing
care. In contrast, PG-protocol 3, which incorporated patient’s
genotype into the warfarin dosing protocol, had the lowest
predicted acute care and ongoing costs associated with ICH at
$119,823.78 for acute care and $125,462.75 for ongoing care.
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For 1,000 AF patients initiating warfarin therapy in Aurora,
switching to a PG protocol would save $55,299.94 in acute care
costs and $59,198.50 in 5-year ongoing care.
Conclusion: At a cost of $59.20 per patient, warfarin PG
dosing is cost neutral. With substantial decreases in genotyping
cost in recent years, it is likely this price is currently achievable.
Therefore, although there is only incremental clinical benefit
from warfarin PG dosing, it is likely cost-effective.
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Background: The Institute for Healthcare Improvement’s Triple
Aim focuses on improving the patient’s experience of care,
improving population health and reducing the per capita cost
of health care. Health care systems and providers continuously
seek to improve quality of care through understanding what
percentage of their patients are achieving quality-of-care
standards for various indicators, including immunizations,
tobacco cessation, asthma and cancer screening. As health care
moves toward reimbursing for value-based care, deepening our
understanding of patient population characteristics within each
of these conditions is vital to continuous quality improvement.
Purpose: To determine if there are race/ethnicity/age/preferred
language (REAL) disparities in care to patients 50 years old or
older who are eligible for colorectal cancer (CRC) screening in
family medicine residency clinics.
Methods: A retrospective analysis of all patients eligible for
CRC screening at two Milwaukee-based family medicine
residency teaching clinics (referred to as FM1 and FM2) and
nonacademic clinics in greater Milwaukee (NAC-MKE) during
a 12-month period (December 2014 – November 2015) was
undertaken in collaboration with health care system quality
improvement specialists. Percentage of patients achieving
CRC screening metric was reported by REAL and gender.
As the ultimate goal was to identify subpopulations to target
for improvement, categories with N < 25 were omitted and
criterion for disparity within a category was defined as > 10%.
Results: The largest CRC screening disparity was associated
with age, with gaps ranging from 13% to 15% between
populations > 65 years old versus 50–54 years old: NAC-MKE
(79% vs 66%), FM1 (81% vs 68%), and FM2 (80% vs 65%).
CRC screening disparities varied by black/African-American
race per location, 54% at NAC-MKE and 67% at FM2 (N ≤ 25
at FM1). Other race, ethnicity and gender were < 10%.
Conclusion: Per the Centers for Disease Control and
Prevention, the African-American/black race has the highest
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CRC death, making early CRC screening an imperative. While
the Wisconsin Collaborative for Healthcare Quality ranks
Aurora Health Care as eighth out of 20 systems in Wisconsin
(77.6% from 2014 Q3 to 2015 Q2), local data analysis identified
age as the largest disparity gap. Analyzing local population
REAL/gender data provides key insights to support initiatives
to reduce health disparity gaps and further progress toward
achieving the Triple Aim for health care.

agreed (4.6) that the overall “returns” from participating were
worth their investments (time, effort).
Conclusion: The WISE-FM provides a statewide faculty
development model that can be adopted by others to meet
accreditation requirements for CP teaching skill development
through shared authoring of CP development resources
while concurrently advancing the development of WISE-FM
participants.
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Background: In many states, family medicine residencies and
medical schools compete clinically for patients, educationally
for trainees and, more recently, for community preceptors
(CPs). As Wisconsin’s medical schools and health care systems
have expanded their geographic footprints, our CPs now teach
trainees from competing institutions. Yet residency and medical
student accrediting bodies require faculty and preceptor
development.
Purpose: To evaluate the impact of a statewide collaborative
of family medicine educators on meeting faculty development
needs of our CPs and collaborative members.
Methods: Faculty development leaders representing the three
largest family medicine residency training sponsors in the
state created the Wisconsin Institute of Scholars & Educators
in Family Medicine (WISE-FM). This statewide collaborative
of family medicine educators is comprised of 3 to 4
representatives per sponsor –– both junior and senior educators
to further support their development as faculty –– committed to
developing common preceptor clinical teaching tools. Through
online discussions and half-day WISE-FM meetings, WISEFM participants identified preceptor development needs and
designed highly regarded clinical teacher infographics for these
priority topics. These tools are available for use statewide,
providing CPs with a consistent teaching approach. To
determine infographic value, a brief (< 5 items) parallel form
survey was distributed to and voluntarily completed by: 1) CPs
who received the infographics, and 2) WISE-FM participants.
Item results on a 5-point Likert scale (5 = strongly agree, 1 =
strongly disagree) were analyzed using descriptive statistics.
Results: Forty-two CP infographics recipients and the 11 WISEFM participants completed the evaluations. Results revealed
that faculty development infographics were a time-efficient
(CP: 4.1, WISE-FM: 4.2) and effective way (CP: 4.0, WISEFM: 4.2) to enrich skills as clinical teachers. Both groups intend
to or have incorporated the infographics into their own teaching
(CP: 4.2, WISE-FM: 4.2). WISE-FM respondents strongly
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Background: Liver transplantation is often associated
with massive blood loss due to surgical complexity and the
hemostatic abnormalities of end-stage liver disease. Blood
transfusions have been associated with increased risk of
infection, multiorgan dysfunction, graft loss and mortality.
Purpose: To determine for liver transplantation whether
correlation exists between preoperative anemia and transfusion
requirements, length of stay or incidence of postoperative
infection.
Methods: A retrospective review of liver transplantations
from Jan. 1, 2012, to June 30, 2015, was conducted. Packed
red blood cell (PRBC), fresh frozen plasma (FFP), platelet
and cryoprecipitate units were collected preoperatively,
intraoperatively and within the first 48 hours postoperatively.
Cox proportional hazards model was used to model the outcome
of infection. Linear regression was used to model the outcomes
of postoperative length of stay and blood use.
Results: Of the 112 patients, mean age was 56 years, mean
Model for End-Stage Liver Disease score was 27 and
mean preoperative hemoglobin was 10.5 g/dL. Lower
preoperative hemoglobin was significantly associated with
increased preoperative PRBC, platelet and cryoprecipitate
use (P<0.04) as well as increased intraoperative PRBC, FFP,
platelet and cryoprecipitate use (P<0.0001). Preoperative
PRBC, FFP, and platelets as well as intraoperative PRBCs
were associated with longer length of stay (P<0.045). Each
g/dL decrease in preoperative hemoglobin was associated
with a 26% increased risk of infection in univariate models
(hazard ratio [HR]: 1.26, P=0.01). Longer length of stay and
higher preoperative cryoprecipitate, intraoperative FFP and
postoperative FFP also were associated with increased risk
of infection. More units of preoperative cryoprecipitate (HR:
1.07, P<0.01), fewer units of postoperative cryoprecipitate
(HR: 0.19, P<0.01) and more units of postoperative FFP
(HR: 1.75, P<0.01) were associated with infection in
multivariable stepwise selection.
Conclusion: Lower preoperative hemoglobin was associated
with increased preoperative and intraoperative transfusion
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